Perioperative diagnosis of cystosarcoma phyllodes of the breast may be enhanced by MIB-1 index

被引:18
|
作者
Ridgway, PF
Jacklin, RK
Ziprin, P
Harbin, L
Peck, DH
Darzi, AW
Rajan, PB
机构
[1] St Marys Hosp, Imperial Coll Fac Med, Dept Surg Oncol & Technol, London W2 1NY, England
[2] St Marys Hosp, Imperial Coll Fac Med, Dept Pathol, London W2 1NY, England
关键词
phyllodes; Ki-67; MIB-1; fibroadenoma; breast; diagnosis;
D O I
10.1016/j.jss.2004.07.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The recurring theme in cystosarcoma phyllodes (CSP) is one of underdiagnosis by pathologists and undertreatment by surgeons. Major areas of investigation relating to the diagnosis of CSP center on accurate preoperative diagnosis, elucidating the relevance of histological classification with respect to outcome, and identifying novel markers to reliably differentiate CSP from fibroadenoma (FA). Materials and methods. Fifteen CSP and 7 cellular FA controls (where the preoperative diagnosis was unclear) were retrospectively investigated. Preoperative histological and radiological investigations were reviewed for efficacy. The ability of MIB-1 antibody to differentiate the two fibroepithelial lesions was investigated using immunohistochemical estimation of the MIB-1 index. Results and discussion. Preoperative core biopsy had a sensitivity of 75% but was carried out in only 23% of cases. Fine needle aspiration cytology and radiological assessment were not efficacious in preoperative diagnosis. Proliferative activity (MIB-1 indices) was significantly higher in CSP than in a selected population of FA where there was preoperative diagnostic uncertainty (P < 0.0001). Indices were also able to determine CSP subclassification. This suggests MlB-1 as a constructive adjunctive investigation when evaluating histological features to differentiate CSP from FA in difficult cases. Conclusions. The use of MlB-1 may increase the sensitivity of preoperative core biopsy diagnosis, offering more effective surgical planning and decreasing immediate reoperation rates. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [31] MIB-1 staining index and peritumoral brain edema of meningiomas
    Ibe, M
    Jimbo, M
    Yamamoto, M
    Umebara, Y
    Hagiwara, S
    Kubo, O
    CANCER, 1996, 78 (01) : 133 - 143
  • [32] The clinical significance of MIB-1 labeling index in pituitary adenomas
    Geeta Chacko
    Ari G. Chacko
    Kalman Kovacs
    Bernd W. Scheithauer
    Sunithi Mani
    J. P. Muliyil
    M. S. Seshadri
    Pituitary, 2010, 13 : 337 - 344
  • [33] MIB-1 labeling index in astrocytic tumors a clinicopathologic study
    Neder, L
    Colli, BO
    Machado, HR
    Carlotti, CG
    Santos, AC
    Chimelli, L
    CLINICAL NEUROPATHOLOGY, 2004, 23 (06) : 262 - 270
  • [34] Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma
    Nishi, T
    Kuratsu, JI
    Takeshima, H
    Saito, Y
    Kochi, M
    Ushio, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 3 (02) : 157 - 161
  • [35] Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer
    Thor, AD
    Liu, SQ
    Moore, DH
    Edgerton, SM
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 470 - 477
  • [36] BGX-Ki-67 Index as a Supplementary Marker to MIB-1 Index, Enabling More Precise Distinction Between Luminal A and B Subtypes of Breast Carcinoma and Eliminating the Problem of Membranous/Cytoplasmic MIB-1 Staining
    Niemiec, Joanna
    Adamczyk, Agnieszka
    Ambicka, Aleksandra
    Mucha-Malecka, Anna
    Wysocki, Wojciech M.
    Majchrzyk, Kaja
    Rys, Janusz
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (03) : 419 - 429
  • [37] Recurrent central neurocytoma with marked increase in MIB-1 labelling index
    Christov, C
    Adle-Biassette, H
    Le Guerinel, C
    BRITISH JOURNAL OF NEUROSURGERY, 1999, 13 (05) : 496 - 499
  • [38] Lack of prognostic significance of an optimized MIB-1 labeling index.
    Grzybicki, DM
    Liu, YL
    Brown, HG
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 517 - 517
  • [39] PROLIFERATION INDEX IN MYELODYSPLASIA DETERMINED BY MIB-1 PARAFFIN SECTION IMMUNOHISTOCHEMISTRY
    CHEN, PY
    MOSKOW, JM
    RAPPAPORT, ES
    ARBER, DA
    LABORATORY INVESTIGATION, 1994, 70 (01) : A105 - A105
  • [40] Extraventricular neurocytoma with MIB-1 labelling index over 10% in a child
    Messina, R.
    Zambuto, M. R.
    Calace, A.
    De Tommasi, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 771 - 771